Alopecia Areata Aa clinical trials

Explore recruiting alopecia areata aa clinical trials.

Recruiting alopecia areata aa studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alopecia Areata Aa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

I4V-MC-JAIO: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Baricitinib in Children from 6 Years to less than 18 Years of Age with Alopecia Areata

France, Poland, Spain, Hungary, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, randomized, double-blind, placebo-controlled, parallel group, 3-arm, multinational, multicenter, proof-of-concept study to evaluate the efficacy and safety of amlitelimab monotherapy by subcutaneous injection in adult participants with severe alopecia areata

Italy, Netherlands, Czechia, Romania, Germany, France +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Alopecia Areata Aa trials by city

Alopecia Areata Aa in Toronto Alopecia Areata Aa in Vancouver Alopecia Areata Aa in Montreal Alopecia Areata Aa in Calgary Alopecia Areata Aa in Edmonton Alopecia Areata Aa in Ottawa Alopecia Areata Aa in Winnipeg Alopecia Areata Aa in Quebec City Alopecia Areata Aa in Hamilton Alopecia Areata Aa in Kitchener Alopecia Areata Aa in London Alopecia Areata Aa in Halifax Alopecia Areata Aa in New York Alopecia Areata Aa in Los Angeles Alopecia Areata Aa in Chicago Alopecia Areata Aa in Houston

Alopecia Areata Aa clinical trials

Recruiting alopecia areata aa studies right now

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

Regeneron AA Multicenter (Dupilumab)

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Also recruiting in Europe

I4V-MC-JAIO: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Baricitinib in Children from 6 Years to less than 18 Years of Age with Alopecia Areata

A Phase 2, randomized, double-blind, placebo-controlled, parallel group, 3-arm, multinational, multicenter, proof-of-concept study to evaluate the efficacy and safety of amlitelimab monotherapy by subcutaneous injection in adult participants with severe alopecia areata

Alopecia Areata Aa trials by city

Other conditions